Terug
Dagbereik
€ 6,71
€ 7,11
52-Weeksbereik
€ 2,68
€ 13,24
Volume
1.637.356
50D / 200D Gem.
€ 7,61
/
€ 7,71
Vorige Slotkoers
€ 6,98
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -2,3 | 0,3 |
| P/B | 1,4 | 2,9 |
| ROE % | -62,6 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 13,75
+97.3%
Low: € 11,00
High: € 18,00
Forward WPA
-€ 3,12
Omzet Sch.
1,7 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,80
-€ 0,06 – € 2,25
|
320 M | 2 |
| FY2029 |
-€ 0,01
-€ 0,03 – € 0,00
|
220 M | 2 |
| FY2028 |
-€ 1,30
-€ 2,80 – -€ 0,39
|
150 M | 4 |
Belangrijkste Punten
Debt/Equity of 0,18 — conservative balance sheet
Negative free cash flow of -198,94M
PEG of 0,61 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-62,58%
ROIC-39,88%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,18
Current Ratio7,95
Interest Coverage-33,15
Waardering
P/E Ratio
-2,33
P/B Ratio1,38
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -247,30M |
| ROE | -62,58% | ROA | -44,85% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -198,94M |
| ROIC | -39,88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,18 | Current Ratio | 7,95 |
| Interest Coverage | -33,15 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -2,33 | P/B Ratio | 1,38 |
| P/S Ratio | N/A | PEG Ratio | 0,61 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 575,53M | Enterprise Value | 540,58M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -247,30M | -215,79M | -174,28M | -118,04M | -80,87M |
| EPS (Diluted) | -3,07 | -3,24 | -2,99 | -2,26 | -1,75 |
| Gross Profit | 0,0 | 0,0 | 0,0 | -4,58M | -4,14M |
| Operating Income | -261,63M | -234,77M | -177,08M | -121,48M | -82,76M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 551,33M | 487,72M | 646,59M | 461,19M | 543,10M |
| Total Liabilities | 135,49M | 113,21M | 91,30M | 49,96M | 44,37M |
| Shareholders' Equity | 415,84M | 374,51M | 555,29M | 411,23M | 498,73M |
| Total Debt | 76,17M | 75,87M | 60,76M | 32,84M | 33,28M |
| Cash & Equivalents | 111,12M | 74,46M | 146,59M | 105,95M | 182,52M |
| Current Assets | 495,88M | 433,67M | 592,60M | 403,98M | 483,75M |
| Current Liabilities | 62,36M | 40,44M | 33,83M | 20,76M | 14,55M |